Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.44 - $13.52 $19,296 - $181,168
13,400 Added 58.9%
36,150 $58,000
Q2 2022

Aug 15, 2022

BUY
$2.52 - $14.42 $18,156 - $103,896
7,205 Added 46.35%
22,750 $58,000
Q1 2022

May 16, 2022

BUY
$12.69 - $20.72 $73,437 - $119,906
5,787 Added 59.31%
15,545 $216,000
Q4 2021

Feb 14, 2022

SELL
$19.7 - $23.71 $374,300 - $450,490
-19,000 Reduced 66.07%
9,758 $202,000
Q3 2021

Nov 15, 2021

BUY
$21.32 - $29.36 $59,973 - $82,589
2,813 Added 10.84%
28,758 $640,000
Q2 2021

Aug 16, 2021

BUY
$17.01 - $24.14 $58,123 - $82,486
3,417 Added 15.17%
25,945 $613,000
Q1 2021

May 17, 2021

BUY
$21.8 - $36.52 $120,488 - $201,846
5,527 Added 32.51%
22,528 $541,000
Q4 2020

Feb 16, 2021

BUY
$23.44 - $31.85 $398,503 - $541,481
17,001 New
17,001 $457,000

Others Institutions Holding VAPO

About VAPOTHERM INC


  • Ticker VAPO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,697,200
  • Market Cap $57.9M
  • Description
  • Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...
More about VAPO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.